ABL Share Price

Open 43.30 Change Price %
High 43.30 1 Day -0.15 -0.35
Low 43.30 1 Week 0.07 0.16
Close 43.30 1 Month 1.90 4.59
Volume 11 1 Year 5.78 15.41
52 Week High 44.58
52 Week Low 34.99
ABL Important Levels
Resistance 2 43.30
Resistance 1 43.30
Pivot 43.30
Support 1 43.30
Support 2 43.30
ETR Germany Most Active Stocks
DTE 15.46 0.78%
DTE 15.46 0.78%
DTE 15.46 0.78%
DTE 15.46 0.78%
DTE 15.46 0.78%
CBK 11.23 0.18%
CBK 11.23 0.18%
EOAN 9.31 1.20%
EOAN 9.31 1.20%
DBK 13.90 -0.29%
ETR Germany Top Gainers Stocks
S9H 0.16 45.45%
MGN 2.96 21.31%
MGN 2.96 21.31%
5M71 39.00 13.70%
R3Q 0.11 10.00%
F3A 44.00 8.40%
AB1 0.43 7.50%
TPE 5.09 7.16%
USE 0.15 7.14%
BEO 3.38 6.96%
ETR Germany Top Losers Stocks
MPI 0.25 -98.98%
MPI 0.25 -98.98%
RLI 21.06 -51.71%
RLI 21.06 -51.71%
APL 2.60 -34.18%
APL 2.60 -34.18%
APL 2.60 -34.18%
MXW 4.15 -23.15%
ANO 0.08 -11.11%
ANO 0.08 -11.11%

Abbott Laboratories (ETR: ABL)

ABL Technical Analysis 4
As on 22nd Sep 2017 ABL Share Price closed @ 43.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 40.10 & Buy for SHORT-TERM with Stoploss of 42.43 we also expect STOCK to react on Following IMPORTANT LEVELS.
ABL Target for September
1st Target up-side 43.38
2nd Target up-side 44.04
3rd Target up-side 44.7
1st Target down-side 41.5
2nd Target down-side 40.84
3rd Target down-side 40.18
ABL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.abbott.com
ABL Address
100 Abbott Park Road
Abbott Park, IL 60064
United States
Phone: 847-937-6100
ABL Latest News
Interactive Technical Analysis Chart Abbott Laboratories ( ABL ETR Germany )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Abbott Laboratories
ABL Business Profile
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.